TOL-101

N/A

Report date: 2025/12/19 14:22:27

Base Information

Drug NameTOL-101
Drug Alias NameTOL101mAb (Tolera Therapeutics)Monoclonal antibody (Tolera Therapeutics)TOL 101TOL-101
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody murine
Mechanisms of ActionT-cell receptor antagonists
TargetsT-cell receptor
Therapy Area/IndicationsRejection of renal transplantationKidney Failure, Chronic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesThe Cleveland Clinic Foundation
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTolera Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsRejection of renal transplantationKidney Failure, Chronic

Other Information

ATC CodeN/A
Related LinksN/A